PRTG (Portage Biotech) Scaled Net Operating Assets : -0.20 (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Portage Biotech Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Portage Biotech's operating assets for the quarter that ended in Sep. 2024 was $0.94 Mil. Portage Biotech's operating liabilities for the quarter that ended in Sep. 2024 was $1.98 Mil. Portage Biotech's Total Assets for the quarter that ended in Jun. 2024 was $5.24 Mil. Therefore, Portage Biotech's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was -0.20.

Portage Biotech Scaled Net Operating Assets Historical Data

The historical data trend for Portage Biotech's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech Scaled Net Operating Assets Chart

Portage Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.84

0.85

0.81

0.33

-0.02

Portage Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.65	0.28	-0.03	-0.19	-0.20

Competitive Comparison of Portage Biotech's Scaled Net Operating Assets

For the Biotechnology subindustry, Portage Biotech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Portage Biotech's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Portage Biotech's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Portage Biotech's Scaled Net Operating Assets falls into.

Portage Biotech Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Portage Biotech's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(2.751	-	4.403)	/	99.129
=	-0.02

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	7.779	-	5.028
=	2.751

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	4.45	-	0.007	-	0.04
=	4.403

Portage Biotech's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(0.942	-	1.983)	/	5.237
=	-0.20

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2.706	-	1.764
=	0.942

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.011	-	0	-	0.028
=	1.983

Portage Biotech Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Portage Biotech's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Portage Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110

Website

https://www.portagebiotech.com

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.